Cutaneous pseudolymphoma following administration of lornoxicam.
Stavrianeas
Nikolaos G
NG
Katoulis
Alexander C
AC
Bozi
Evangelia
E
Toumbis-Ioannou
Eugenia
E
Kanelleas
Antonios I
AI
Makris
Michael
M
Kalogeromitros
Dimitrios
D
Panayiotides
Ioannis
I
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects*; D001416:Back Pain / Q000188:drug therapy; D006801:Humans; D008297:Male; D010894:Piroxicam / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D019310:Pseudolymphoma / Q000139:chemically induced*; D012871:Skin Diseases / Q000139:chemically induced*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D010894:Piroxicam; C059451:lornoxicam